Literature DB >> 24591403

Pathological characteristics of early to advanced gallbladder carcinoma and extrahepatic cholangiocarcinoma.

Hiroshi Kijima1, Yunyan Wu, Tadashi Yosizawa, Takahiro Suzuki, Yuta Tsugeno, Toshihiro Haga, Hiroko Seino, Satoko Morohashi, Kenichi Hakamada.   

Abstract

Biliary tract cancer (cancer of gallbladder and extrahepatic bile duct) is the most common malignancy of the biliary tract, and is considered to be a high-grade malignancy. In this study, we reviewed 293 gallbladder cancers and 102 bile duct cancers for clarifying growth and invasion of the extrahepatic bile duct cancer. Only 10.5% (9/86) of the early gallbladder cancers showed lymphatic invasion, but neither venous invasion nor lymph node metastasis was noted in the early cancers. 70.6% (207/293) of the gallbladder cases were pT2-3 cancers, and frequently showed lymphatic/venous/perineural invasion and/or lymph node metastasis. 12.7% (13/102) of the extrahepatic bile duct cancers were pTis or pT1 cancers, which were categorized as early cancers. Only 15.4% (2/13) of the early cancer showed vascular/perineural invasion and/or lymph node metastasis. The majority (87.3%) of the extrahepatic bile duct cases was pT2-3 cancers, and frequently showed vascular/perineural invasion and/or lymph node metastasis. We also examined intramural invasion patterns; i.e. intramural invasion patterns were defined as infiltrative growth (IG) type, and destructive growth (DG) type. The overall survival rate of the gallbladder cancer patients with the DG type was significantly lower than that of the patients with the IG type, associated with frequent lymphatic/venous invasion and/or lymph node metastasis. Therefore, pathological characteristics are important for clinical manifestation of the gallbladder/extrahepatic bile duct cancers.
© 2014 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  Adenocarcinoma; Cancer of gallbladder and extrahepatic bile duct; Invasion; Metastasis; Pathology

Mesh:

Year:  2014        PMID: 24591403     DOI: 10.1002/jhbp.72

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  6 in total

1.  A Novel Prognostic Nomogram for Gallbladder Cancer after Surgical Resection: A Single-Center Experience.

Authors:  Zuyi Ma; Fengying Dong; Zhenchong Li; Zehao Zheng; Zixuan Zhou; Hongkai Zhuang; Chunsheng Liu; Bowen Huang; Shanzhou Huang; Yiping Zou; LinLing Yang; Yuanfeng Gong; Chuanzhao Zhang; Baohua Hou
Journal:  J Oncol       Date:  2021-02-08       Impact factor: 4.375

2.  MicroRNA-155 expression as a prognostic factor in patients with gallbladder carcinoma after surgical resection.

Authors:  Xue-Lin Zhang; Jun-Hong Chen; Cheng-Kun Qin
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 3.  Gallbladder Cancer in the 21st Century.

Authors:  Rani Kanthan; Jenna-Lynn Senger; Shahid Ahmed; Selliah Chandra Kanthan
Journal:  J Oncol       Date:  2015-09-01       Impact factor: 4.375

Review 4.  MicroRNA expression and its implications for diagnosis and therapy of gallbladder cancer.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Priscilla T Y Law; Matthew T V Chan; William K K Wu
Journal:  Oncotarget       Date:  2015-06-10

5.  Role of common bile duct resection in T2 and T3 gallbladder cancer patients.

Authors:  Jin Hong Lim; Jae Uk Chong; Sung Hoon Kim; Seung Woo Park; Jin Sub Choi; Woo Jung Lee; Kyung Sik Kim
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2018-02-26

6.  MRNA Profiling Involved in Triggering of STAT1 with Regulatory Involvement of IRF7, PTPRF, and miR-145p in Patients Suffering from Gall Bladder Carcinoma.

Authors:  Weiwei Zhao; Yanxuan Gong; Yugang Chen
Journal:  J Healthc Eng       Date:  2022-01-07       Impact factor: 3.822

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.